World journal of methodology · 2025
Advances in the treatment of autism spectrum disorder: Wharton jelly mesenchymal stem cell transplantation.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kabatas Serdar, Civelek Erdinç, Savrunlu Eyüp Can, Karaaslan Umut, Yıldız Özlem, Karaöz Erdal
Аннотация
BACKGROUND: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with multifaceted origins. In recent studies, neuroinflammation and immune dysregulation have come to the forefront in its pathogenesis. There are studies suggesting that stem cell therapy may be effective in the treatment of ASD.
AIM: To evolve the landscape of ASD treatment, focusing on the potential benefits and safety of stem cell transplantation.
METHODS: A detailed case report is presented, displaying the positive outcomes observed in a child who underwent intrathecal and intravenous Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) transplantation combined with neurorehabilitation.
RESULTS: The study demonstrates a significant improvement in the child's functional outcomes (Childhood Autism Rating Scale, Denver 2 Developmental Screening Test), especially in language and gross motor skills. No serious side effects were encountered during the 2-year follow-up.
CONCLUSION: The findings support the safety and effectiveness of WJ-MSC transplantation in managing ASD.
AIM: To evolve the landscape of ASD treatment, focusing on the potential benefits and safety of stem cell transplantation.
METHODS: A detailed case report is presented, displaying the positive outcomes observed in a child who underwent intrathecal and intravenous Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) transplantation combined with neurorehabilitation.
RESULTS: The study demonstrates a significant improvement in the child's functional outcomes (Childhood Autism Rating Scale, Denver 2 Developmental Screening Test), especially in language and gross motor skills. No serious side effects were encountered during the 2-year follow-up.
CONCLUSION: The findings support the safety and effectiveness of WJ-MSC transplantation in managing ASD.